Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For 009970.KS
Valuation Somewhat Positive
56%
Profitability n.A.
Fin. Growth Balanced
50%
Leverage & Liquidity Weak
17%
Per Share Metrics Weak
33%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio 2.18 3.52 3.44
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -89.04 -4.11 -2.17
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value 2.20 207431.11 202970.91
Cash 1.36 176249.95 173879.15
Capex 66.89 -3448.03 -10412.75
Free Cash Flow -62.97 8879.19 23977.67
Revenue -24.00 76895.33 101176.97
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin -18.21 0.40 0.48
Operating Margin -29.39 0.13 0.19
ROA -17.57 0.01 0.01
ROE -19.14 0.03 0.04
ROIC -52.47 0.03 0.06
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of 009970.KS is permitted for members.
5 Growth
The "Growth Entry" for the Focus of 009970.KS is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of 009970.KS is permitted for members.